Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2000
06/13/2000CA2118309C Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily
06/13/2000CA2095624C Method of targeting dna
06/13/2000CA2079105C Hepatitis c virus protease
06/13/2000CA2048450C Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria
06/11/2000CA2291912A1 Method and reagent for quantitative determination of 1,5-anhydroglucitol
06/09/2000CA2292124A1 Compositions and methods for generating red chemiluminescence
06/08/2000WO2000033161A2 Methods to reduce variance in treatment studies using genotyping
06/08/2000WO2000033084A2 Arrays of organic compounds attached to surfaces
06/08/2000WO2000033078A1 Porous coatings bearing ligand arrays
06/08/2000WO2000033074A1 Multichemistry measuring device and test strips
06/08/2000WO2000033068A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
06/08/2000WO2000033067A1 Method for diagnosing neoplasia
06/08/2000WO2000033065A1 In vivo biosensor apparatus and method of use
06/08/2000WO2000032826A1 Methods and kits for identifying individuals at risk of developing osteoporosis
06/08/2000WO2000032825A2 Development of anti-microbial agents based on bacteriophage genomics
06/08/2000WO2000032824A2 Length determination of nucleic acid repeat sequences by discontinuous primer extension
06/08/2000WO2000032823A1 Dna-protein fusions and uses thereof
06/08/2000WO2000032822A1 Methods for introducing heterologous cells into fish
06/08/2000WO2000032821A1 Methods for making recombinant cells
06/08/2000WO2000032820A1 Method for detecting target sequences in small proportions in heterogeneous samples
06/08/2000WO2000032819A1 Methods of diagnosing, prognosticating and treating matrix metalloproteinase-1 related diseases via a matrix metalloproteinase-1 single nucleotide polymorphism
06/08/2000WO2000032814A2 Methods for producing selected interstrand cross-links in nucleic acids and applications thereof
06/08/2000WO2000032813A1 Method and system for detecting oligonucleotides in a sample
06/08/2000WO2000032812A1 Method for separating nucleic acids into populations
06/08/2000WO2000032811A2 Method for determining the apolipoprotein-e-genotype in a human sample
06/08/2000WO2000032810A1 $i(in situ) hybridization method using probes containing dendrimer structures
06/08/2000WO2000032809A2 Cloning and copying on surfaces
06/08/2000WO2000032808A1 Method for assaying platelet-activating-factor acetylhydrolase activity
06/08/2000WO2000032806A1 Method for the quantitative determination of proteinase inhibitors
06/08/2000WO2000032805A1 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases
06/08/2000WO2000032794A2 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000WO2000032784A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000WO2000032780A1 Control of flowering
06/08/2000WO2000032775A1 Pth1r and pth3r receptors
06/08/2000WO2000032773A1 Compositions and methods for increasing bone mineralization
06/08/2000WO2000032771A1 Pth1r and pth3r receptors, methods and uses thereof
06/08/2000WO2000032769A2 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides
06/08/2000WO2000032768A1 Polypeptides capable of interacting with the human topoisomerase iii alpha
06/08/2000WO2000032766A1 Human vanilloid receptors and their uses
06/08/2000WO2000032763A1 METHOD FOR SYNTHESIZING cDNA
06/08/2000WO2000032762A1 Magnetic particles for purifying nucleic acids
06/08/2000WO2000032761A1 Ethylene-response-factor1 (erf1) in plants
06/08/2000WO2000032752A1 Psca: prostate stem cell antigen and uses thereof
06/08/2000WO2000032750A1 Transgenic circulating endothelial cells
06/08/2000WO2000032743A1 Apparatus for automatic reading of antibiogram with improved contrast
06/08/2000WO2000032678A1 Solvent resistant photosensitive compositions
06/08/2000WO2000032631A2 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof
06/08/2000WO2000032624A2 Uncoupling protein 5 - ucp5
06/08/2000WO2000032619A1 Methods and compositions for identification of inhibitors of ribosome assembly
06/08/2000WO2000032221A2 Promotion or inhibition of angiogenesis and cardiovascularization
06/08/2000WO2000032215A1 PGC-1, A NOVEL BROWN FAT PPARη COACTIVATOR
06/08/2000WO2000032196A2 Inhibitors of multidrug transporters
06/08/2000WO2000032190A1 Compositions and methods for the treatment of alzheimer's disease, central nervous system injury, and inflammatory diseases
06/08/2000WO2000032152A2 Compositions and methods for regulating bacterial pathogenesis
06/08/2000WO2000032091A2 Diagnosis of gastric and lung disorders
06/08/2000WO2000032059A1 Method for testing a fodder component for the feeding of ruminants
06/08/2000WO2000018923A3 Slgp protein and nucleic acid molecule and uses therefor
06/08/2000WO2000016101A9 Target analyte sensors utilizing microspheres
06/08/2000WO2000016089A3 Signal detection techniques for the detection of analytes
06/08/2000WO2000016062A3 Methods for determining the activity of complex mixtures
06/08/2000WO2000015836A3 Combination of markers at the estrogen- and vitamin d-receptor genes or equivalents thereof to prognose a response to osteoporosis therapy
06/08/2000WO2000015659A3 Stomach polypeptide zsig28
06/08/2000WO2000014275A3 Two-colour differential display, used as a method for detecting regulated genes
06/08/2000WO2000014200A3 Essential bacterial genes and their use
06/08/2000WO2000012704A9 Enhanced functional expression of g protein-coupled receptors
06/08/2000WO2000011191A3 Tpl-2/cot kinase and methods of use
06/08/2000WO2000011183A3 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000WO2000009755A3 Domain specific gene evolution
06/08/2000WO2000009750A9 Compositons, kits, and methods for hydrodynamic stress-related regulation of gene expression
06/08/2000WO2000008212A9 Gel microdrops in genetic analysis
06/08/2000WO2000005419A9 Prevention of metastasis with 5-aza-2'-deoxycytidine
06/08/2000WO2000004137A9 Human aspartic proteases
06/08/2000WO2000001842A8 Screening of hydrolase libraries for enantioselective enzymes
06/08/2000WO1999065938A9 Fy7 polymerase
06/08/2000WO1999064835A8 Screening method for dehydrogenase oligomerisation modulators
06/08/2000WO1999064572A3 Poly(adp-ribose) polymerase gene
06/08/2000DE19958198A1 Mit dem IGF-1 Rezeptor wechselwirkende Proteine (IIPs) With the IGF-1 receptor interacting proteins (IIPs)
06/08/2000DE19854946A1 Klonieren und Kopieren an Oberflächen Cloning and copying at surfaces
06/08/2000CA2851896A1 Plant diacylglycerol acyltransferases
06/08/2000CA2703147A1 Plant diacylglycerol acyltransferases
06/08/2000CA2503475A1 Promotion or inhibition of angiogenesis and cardiovascularization
06/08/2000CA2353795A1 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases
06/08/2000CA2353793A1 Length determination of nucleic acid repeat sequences by discontinuous primer extension
06/08/2000CA2353643A1 Methods for producing selected interstrand cross-links in chromosomal nucleic acids and applications thereof
06/08/2000CA2353575A1 Methods for making recombinant cells
06/08/2000CA2353563A1 Development of novel anti-microbial agents based on bacteriophage genomics
06/08/2000CA2353562A1 Method and system for detecting oligonucleotides in a sample
06/08/2000CA2353557A1 Inhibitors of multidrug transporters
06/08/2000CA2353521A1 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof
06/08/2000CA2353304A1 Polypeptides capable of interacting with the human topoisomerase iii alpha
06/08/2000CA2353107A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000CA2353103A1 Method for separating nucleic acids into populations
06/08/2000CA2353080A1 Control of flowering
06/08/2000CA2352759A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000CA2352568A1 Methods for introducing heterologous cells into fish
06/08/2000CA2352532A1 Compositions and methods for increasing bone mineralization
06/08/2000CA2352468A1 Ethylene-response-factor1 (erf1) in plants
06/08/2000CA2351731A1 Compositions and methods for regulating bacterial pathogenesis
06/08/2000CA2351671A1 Transgenic circulating endothelial cells
06/08/2000CA2350069A1 Methods to reduce variance in treatment studies using genotyping
1 ... 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 ... 3003